Furthermore, intranasal administration of recombinant IL-17A to antibiotic-treated mice rescued defects in respiratory GM-CSF production during infection with either K. pneumoniae or S. pneumoniae (Fig. 2h, i). This evidence concerns the gene CSF2 and infection.